Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Moderna Therapeutics Raises USD125 Million in Series H Preferred Equity Financing 12
Moderna Therapeutics Raises USD450 Million in Venture Financing 13
Moderna Therapeutics Raises Additional USD25 Million in Venture Financing 15
Onkaido Therapeutics To Raise US$20 Million In Venture Financing 16
Moderna Therapeutics Raises US$110 Million In Venture Financing 17
Moderna Therapeutics Raises US$40 Million In Series A Financing 18
Private Equity 19
Moderna Therapeutics Raises USD500 Million in Equity Financing 19
Partnerships 21
Moderna Therapeutics Enters into Agreement with Charles River Labs 21
AstraZeneca Enters into Co-Development Agreement with Moderna Therapeutics 22
Moderna Therapeutics Enters into Agreement with Pharmaceutical Product Development 23
Moderna Therapeutics Enters into Research Agreement with Institut Pasteur 24
Moderna Therapeutics Enters into Discovery Agreement with Karolinska Institutet and Karolinska University Hospital 25
Alexion Pharma And Moderna Therapeutics Enter Into Agreement To Develop Messenger RNA Therapeutics For Rare Diseases 26
AstraZeneca Expands Co-Development Agreement With Moderna Therapeutics For Messenger RNA Therapeutics 27
Licensing Agreements 28
AstraZeneca Enters into Licensing Agreement with Moderna Therapeutics 28
Vertex Pharma Enters into Licensing Agreement with Moderna Therapeutics 29
Merck Expands Licensing Agreement with Moderna Therapeutics 30
Moderna Therapeutics Enters into Licensing Agreement with Avacta Life Sciences 32
Moderna Therapeutics Amends Terms of Licensing Agreement with Merck 33
Equity Offering 35
Moderna Therapeutics Files Registration Statement for USD500 Million in IPO 35
Moderna Therapeutics Raises USD474 Million in Private Placement of Shares 36
AstraZeneca Invests USD140 Million in Moderna Therapeutics 37
Moderna Therapeutics Raises USD50 Million in Private Placement of Shares 38
Moderna Therapeutics Inc – Key Competitors 39
Moderna Therapeutics Inc – Key Employees 40
Moderna Therapeutics Inc – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 43
Corporate Communications 43
Sep 05, 2018: Dr. Wellington Sun joins Moderna as Head, vaccine strategy and regulatory affairs 43
Apr 04, 2018: Megan Pace Joins Moderna as Chief Corporate Affairs Officer 44
Jan 03, 2018: Dr. John Mendlein Joins Moderna as President, Corporate and Product Strategy 45
Oct 10, 2017: Stephen Berenson Joins Modernas Board of Directors 46
Aug 03, 2017: Industry Veteran Juan Andres Joins Moderna as Senior Vice President of Late Stage Technical Development and Manufacturing 47
Jul 27, 2017: Moncef M. Slaoui, Ph.D. Joins Moderna’s Board of Directors 49
Feb 22, 2017: Moderna Appoints Israel Ruiz to its Board of Directors 50
Product News 51
07/13/2017: Publication in Cell Demonstrates Modernas Zika mRNA Vaccine Prevents In Utero Transmission of Zika Virus in Mice, Protects Against Zika-Related Congenital Damage 51
Clinical Trials 53
Nov 15, 2017: Moderna Announces First-in-Human Dosing for Phase 1 Study (KEYNOTE-603) of mRNA-4157, a Personalized Cancer Vaccine, for the Treatment of Solid Tumors 53
Apr 27, 2017: Moderna Announces Positive Interim Phase 1 Clinical Data Demonstrating First mRNA Vaccine Candidate, mRNA-1440, Induces High Levels of Immunogenicity 54
Other Significant Developments 57
Jul 11, 2018: Moderna Provides Mid-Year Corporate Update 57
Jan 08, 2018: Moderna Announces an Array of Clinical Advances and Outlines 2018 Priorities; 19 Development Candidates, including 10 Clinical Programs, Highlight Productivity of mRNA Platform 61
Sep 14, 2017: Moderna Announces Pipeline and Corporate Update 64
Jul 27, 2017: Moderna Provides Update on mRNA Rare Disease R&D Strategy 70
Jan 09, 2017: Moderna Provides Pipeline and Full-Year Corporate Update 71
Appendix 76
Methodology 76
About GlobalData 76
Contact Us 76
Disclaimer 76
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Moderna Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Moderna Therapeutics Raises USD125 Million in Series H Preferred Equity Financing 12
Moderna Therapeutics Raises USD450 Million in Venture Financing 13
Moderna Therapeutics Raises Additional USD25 Million in Venture Financing 15
Onkaido Therapeutics To Raise US$20 Million In Venture Financing 16
Moderna Therapeutics Raises US$110 Million In Venture Financing 17
Moderna Therapeutics Raises US$40 Million In Series A Financing 18
Moderna Therapeutics Raises USD500 Million in Equity Financing 19
Moderna Therapeutics Enters into Agreement with Charles River Labs 21
AstraZeneca Enters into Co-Development Agreement with Moderna Therapeutics 22
Moderna Therapeutics Enters into Agreement with Pharmaceutical Product Development 23
Moderna Therapeutics Enters into Research Agreement with Institut Pasteur 24
Moderna Therapeutics Enters into Discovery Agreement with Karolinska Institutet and Karolinska University Hospital 25
Alexion Pharma And Moderna Therapeutics Enter Into Agreement To Develop Messenger RNA Therapeutics For Rare Diseases 26
AstraZeneca Expands Co-Development Agreement With Moderna Therapeutics For Messenger RNA Therapeutics 27
AstraZeneca Enters into Licensing Agreement with Moderna Therapeutics 28
Vertex Pharma Enters into Licensing Agreement with Moderna Therapeutics 29
Merck Expands Licensing Agreement with Moderna Therapeutics 30
Moderna Therapeutics Enters into Licensing Agreement with Avacta Life Sciences 32
Moderna Therapeutics Amends Terms of Licensing Agreement with Merck 33
Moderna Therapeutics Files Registration Statement for USD500 Million in IPO 35
Moderna Therapeutics Raises USD474 Million in Private Placement of Shares 36
AstraZeneca Invests USD140 Million in Moderna Therapeutics 37
Moderna Therapeutics Raises USD50 Million in Private Placement of Shares 38
Moderna Therapeutics Inc, Key Competitors 39
Moderna Therapeutics Inc, Key Employees 40
Moderna Therapeutics Inc, Subsidiaries 42
List of Figures
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Moderna Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9